Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

about

Glucagonoma syndrome: a review and update on treatment.Glucagonoma and the glucagonoma syndrome.Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.

P2860

Q38898616-6198F0EB-CB4E-4126-876B-68DBF295A91A Q49471166-F87C383F-0A8D-49FC-98B1-934E32391511 Q50079728-4EE7EF7E-F1FE-4780-86D2-605AABCF33B2 Q53833734-A8E40FDD-E1BA-480A-BCBE-CB54F67AAABF

P2860

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

Item

http://www.wikidata.org/entity/Q53422328

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@en

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@nl

type

Item

label

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@en

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@nl

prefLabel

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@en

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@nl

P1476

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

@en

P2093

Atsushi Fukunaga

http://www.w3.org/2001/XMLSchema#string

Chikako Nishigori

http://www.w3.org/2001/XMLSchema#string

Hironobu Minami

http://www.w3.org/2001/XMLSchema#string

Masahiro Oka

http://www.w3.org/2001/XMLSchema#string

Masanori Toyoda

http://www.w3.org/2001/XMLSchema#string

Naoko Chayahara

http://www.w3.org/2001/XMLSchema#string

Shiro Kimbara

http://www.w3.org/2001/XMLSchema#string

Toru Mukohara

http://www.w3.org/2001/XMLSchema#string

Yoshinori Imamura

http://www.w3.org/2001/XMLSchema#string

P2860

New strategies for advanced neuroendocrine tumors in the era of targeted therapy

Necrolytic migratory erythema: clinicopathologic study of 13 cases

The glucagonoma syndrome and necrolytic migratory erythema: a clinical review

CUTANEOUS MANIFESTATIONS OF INTERNAL MALIGNANT TUMORS

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.

Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

P2888

s12328-014-0471-9

P304

255-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12328-014-0471-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Naomi Kiyota

Yutaka Fujiwara

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26183746

http://www.w3.org/2001/XMLSchema#string

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

about

P2860

P2860

Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698